Difficulty: Medium
Average Score: 71%
Practice
Atropine causes:
Correct answer
B
Rationale
Atropine is a medication that exerts its effects by blocking the action of acetylcholine in the body. The correct answer, B) Mydriasis, a rise in intraocular pressure and cycloplegia, aligns with the pharmacological actions of atropine. Mydriasis refers to the dilation of the pupil, which occurs because atropine inhibits the parasympathetic nervous system, leading to the dominance of the sympathetic system causing pupil dilation. Intraocular pressure rises due to the inhibition of the pupillary constrictor muscle, leading to a decrease in the drainage of aqueous humor. Cycloplegia refers to the paralysis of the ciliary muscle in the eye, leading to the loss of accommodation.
Option A, miosis, a reduction in intraocular pressure, and cyclospasm, is incorrect because atropine causes pupil dilation (mydriasis) instead of constriction (miosis). It also leads to an increase in intraocular pressure rather than a reduction, and it causes cycloplegia, not cyclospasm.
Option C, miosis, a rise in intraocular pressure, and cyclospasm, is incorrect for similar reasons as option A. Atropine causes mydriasis, an increase in intraocular pressure, and cycloplegia, not miosis or cyclospasm.
Option D, mydriasis, a rise in intraocular pressure, and cyclospasm, is incorrect because atropine does not cause cyclospasm but rather cycloplegia. It also leads to an increase in intraocular pressure, not a reduction.
Understanding the pharmacological effects of atropine is crucial for healthcare professionals, especially in ophthalmology and emergency medicine settings. By grasping how atropine influences pupil size, intraocular pressure, and accommodation, healthcare providers can make informed decisions when prescribing or administering this medication. This knowledge also contributes to a broader understanding of pharmacology and its implications across different patient populations, emphasizing the importance of considering lifespan considerations when managing drug therapies.
Option A, miosis, a reduction in intraocular pressure, and cyclospasm, is incorrect because atropine causes pupil dilation (mydriasis) instead of constriction (miosis). It also leads to an increase in intraocular pressure rather than a reduction, and it causes cycloplegia, not cyclospasm.
Option C, miosis, a rise in intraocular pressure, and cyclospasm, is incorrect for similar reasons as option A. Atropine causes mydriasis, an increase in intraocular pressure, and cycloplegia, not miosis or cyclospasm.
Option D, mydriasis, a rise in intraocular pressure, and cyclospasm, is incorrect because atropine does not cause cyclospasm but rather cycloplegia. It also leads to an increase in intraocular pressure, not a reduction.
Understanding the pharmacological effects of atropine is crucial for healthcare professionals, especially in ophthalmology and emergency medicine settings. By grasping how atropine influences pupil size, intraocular pressure, and accommodation, healthcare providers can make informed decisions when prescribing or administering this medication. This knowledge also contributes to a broader understanding of pharmacology and its implications across different patient populations, emphasizing the importance of considering lifespan considerations when managing drug therapies.